Back to Search
WARREN LOOS, PH.D.
PH.D.
Clinical Psychologist
NPI: 1548360167IndividualAccepts Medicare
Specialties, Licenses & Credentials
Clinical PsychologistPrimary
Psychologist — Clinical
Code: 103TC0700X
PSY-792(HI)
CMS Specialties
PrimaryCLINICAL PSYCHOLOGIST
Education
OTHER
Class of 1988
Research & Publications (20)
Validated bioanalytical method for the quantification of RGB-286638, a novel multi-targeted protein kinase inhibitor, in human plasma and urine by liquid chromatography/tandem triple-quadrupole mass spectrometry.
PMID 19628352·J Pharm Biomed Anal·2009
8-other
Application of prolonged microdialysis sampling in carboplatin-treated cancer patients.
PMID 19096847·Cancer Chemother Pharmacol·2009
8-other
Topotecan distribution in an anephric infant with therapy-resistant bilateral Wilms tumor with a novel germline WT1 gene mutation.
PMID 18273617·Cancer Chemother Pharmacol·2008
8-other
Interaction of Cisplatin with the human organic cation transporter 2.
PMID 18559608·Clin Cancer Res·2008
3-trial
Continuous ambulatory peritoneal dialysis: pharmacokinetics and clinical outcome of paclitaxel and carboplatin treatment.
PMID 18204842·Cancer Chemother Pharmacol·2008
5-case
The pharmacologic basis of ifosfamide use in adult patients with advanced soft tissue sarcomas.
PMID 18055856·Oncologist·2007
6-review
Medicinal cannabis does not influence the clinical pharmacokinetics of irinotecan and docetaxel.
PMID 17405893·Oncologist·2007
8-other
Aprepitant when added to a standard antiemetic regimen consisting of ondansetron and dexamethasone does not affect vinorelbine pharmacokinetics in cancer patients.
PMID 17051369·Cancer Chemother Pharmacol·2007
8-other
Cigarette smoking and irinotecan treatment: pharmacokinetic interaction and effects on neutropenia.
PMID 17563393·J Clin Oncol·2007
3-trial
Flat-fixed dosing versus body surface area based dosing of anticancer drugs in adults: does it make a difference?
PMID 17766650·Oncologist·2007
8-other
Pitfalls of the application of microdialysis in clinical oncology: controversial findings with docetaxel.
PMID 17804188·J Pharm Biomed Anal·2007
8-other
Influence of ketoconazole on the fecal and urinary disposition of docetaxel.
PMID 17256132·Cancer Chemother Pharmacol·2007
8-other
Irinotecan chemotherapy during valproic acid treatment: pharmacokinetic interaction and hepatotoxicity.
PMID 17873515·Cancer Biol Ther·2007
5-case
Hepatic transport, metabolism and biliary excretion of irinotecan in a cancer patient with an external bile drain.
PMID 16969123·Cancer Biol Ther·2006
5-case
Quantification of [3H]docetaxel in feces and urine: development and validation of a combustion method.
PMID 16317291·Anticancer Drugs·2006
8-other
A pharmacokinetic interaction study of docetaxel and cisplatin plus or minus 5-fluorouracil in the treatment of patients with recurrent or metastatic solid tumors.
PMID 16544143·Cancer Chemother Pharmacol·2006
4-observational
Evaluation of an alternate dosing strategy for cisplatin in patients with extreme body surface area values.
PMID 16574999·J Clin Oncol·2006
2-rct
A phase I study assessing the safety and pharmacokinetics of the thrombospondin-1-mimetic angiogenesis inhibitor ABT-510 with gemcitabine and cisplatin in patients with solid tumors.
PMID 16728485·Ann Oncol·2006
3-trial
Influence of high-dose ketoconazole on the pharmacokinetics of docetaxel.
PMID 16775418·Cancer Biol Ther·2006
2-rct
The relevance of microdialysis for clinical on:cology.
PMID 18666750·Curr Clin Pharmacol·2006
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 4300 WAIALAE AVE APT B1002
HONOLULU, HI 96816 - Phone
- (808) 284-2200
Quick Facts
- NPI
- 1548360167
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 38
- Publications
- 20
Are you this provider?
Claim Your Profile